Jason Hyatt

JASON HYATT focuses his practice on corporate and securities matters and represents domestic and foreign private issuers and underwriters in a variety of SEC-registered and exempt transactions, including initial public offerings, SPAC and de-SPAC transactions, common and preferred equity offerings, and debt offerings. Jason also advises clients on corporate governance matters and ongoing disclosure obligations, including compliance with the Exchange Act disclosure requirements, New York Stock Exchange, and Nasdaq corporate governance rules. Prior to joining Sidley, Jason was an associate in the London office of another leading international law firm and an associate in the New York offices of international law firms. Jason also spent time on secondment to the New York office of a major international bank.

While attending Emory University School of Law, Jason was an article editor for the Emory Law Journal.

Jason serves as a member of the Alumni Board of Emory University School of Law.

Jason has advised issuers, underwriters, and other market participants on transactions in the U.S. and EMEA equity and debt capital markets including:
Equity Offerings:

• The underwriters in connection with the upsized, underwritten public offering of ordinary shares of a leading global provider of drug containment and delivery solutions for the pharmaceutical, biotechnology, and life science industries.
• A clinical-stage biopharmaceutical company in connection with the establishment of an at-the-market equity program.
• A Swedish-Swiss multinational electrical engineering corporation on U.S. law matters in connection with its spinoff and Switzerland’s principal stock exchange listing of its turbocharging business.
• A healthcare technology company in connection with its initial public offering.
•  The underwriters in connection with the initial public offering of shares of common stock of a clinical-stage targeted oncology company.
• A biopharmaceutical company in connection with its public offering of shares of common stock.
• An Ireland-based pharmaceutical company in connection with its public offering of ordinary shares (or pre-funded warrants in lieu thereof).
• The underwriters in connection with the public offering of shares of common stock by a clinical-stage biopharmaceutical company.
• A French, late-stage, clinical biotechnology company in connection with its initial public offering.
• An American advertising company in connection with its $400 million private placement of 400,000 shares of Series A Convertible Perpetual Preferred Stock.
• A French biopharmaceutical company in connection with its public offering of American Depositary Shares.
• A biotechnology company in connection with its public follow-on offering of common stock.

SPAC Transactions:

• A global digital operator and its digital operator in Ukraine in connection with the execution of a business combination agreement with a SPAC.
• A private equity firm and a leading supplier of copper specialty products in connection with its execution of a business combination agreement with a SPAC.
• Represented 10X Capital in connection with its de-SPAC transaction with a global food security company operating a commercial-scale alfalfa farm on the African continent.
• Represented 10X Capital in connection with its business combination agreement with a clinical-stage, HIV-focused, gene therapy company.
• Represented 10X Capital in connection with its business combination agreement with a diversified infrastructure provider and blockchain technology company.

Debt Offerings:

• An American global financial services and bank holding company in its $850 million, registered, senior subordinated notes offering.
• A leading manufacturer and distributor of packaging and tissue products in connection with the issuance of US$300 million in aggregate principal amount of senior notes in a Rule 144A and Regulation S offering, as well as a tender offer for any and all outstanding principal amounts of US$200 million senior notes.
• An American advertising company in connection with issuances of senior notes in Rule 144A and Regulation S offerings.
• The underwriters in connection with several public note offerings by a leading food and beverage company.

The above matters were handled by Jason prior to joining Sidley.